Cervical Total Disc Replacement

Early results of an investigational device exemption clinical trial showed two prodisc C implants may be safe and effective for the treatment of symptomatic cervical disc disease at two levels compared with the Mobi-C implant at 24 months.

Aurora Spine Corporation has announced FDA 510(k) clearance for the Apollo anterior cervical plate system, according to a press release.

Preliminary results from an FDA investigational device exemption study showed a clinically significant decrease in pain and increase in function with the use of a PEEK-on-ceramic device in two-level cervical total disc replacement.